Serum concentrations of squamous-cell carcinoma antigen and tissue polypeptide antigen in the follow-up of patients with vulvar cancer

International Journal of Cancer

Volumn 83, Issue 2, 1999, Pages 167-170

  Hefler, Lukas ^a   Frischmuth, Katrin ^a   Heinze, Georg ^a   Sliutz, Gerhard ^a   Leodolter, Sepp ^a   Reinthaller, Alexander ^a   Kainz, Christian ^a   Tempfer, Clemens ^b  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

^b BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

TISSUE POLYPEPTIDE ANTIGEN;

ADULT; AGED; ANTIGEN DETECTION; ARTICLE; CANCER RECURRENCE; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DISEASE MARKER; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; RECURRENCE RISK; SQUAMOUS CELL CARCINOMA; VULVA CANCER;

ADULT; AGED; AGED, 80 AND OVER; ANTIGENS, NEOPLASM; CARCINOMA, SQUAMOUS CELL; FEMALE; FOLLOW-UP STUDIES; HUMANS; MIDDLE AGED; NEOPLASM INVASIVENESS; NEOPLASM RECURRENCE, LOCAL; SENSITIVITY AND SPECIFICITY; SERPINS; TISSUE POLYPEPTIDE ANTIGEN; TUMOR MARKERS, BIOLOGICAL; VULVAR NEOPLASMS;

EID: 0032882584     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0215(19991008)83:2<167::AID-IJC4>3.0.CO;2-E     Document Type: Article

References (30)

1. AMERICAN SOCIETY OF CLINICAL ONCOLOGY, Clinical practice guidelines for the use of tumor markers in breast and colorectal cancer. J. clin. Oncol., 14, 2843-2877 (1996).
2. CHAN, K. and HELM, C., Invasive vulvar cancer. In: H. Shingleton, W. Fowler, J. Jordan and W. Lawrence (eds.), Gynecologic oncology: current diagnosis and treatment, pp. 264-272, Saunders, London (1996).
3. DE BRUIJN, H., TEN HOOR, K. and VAN DER ZEE, A., Rising serum values of beta-subunit human chorionic gonadotropin (hCG) in patients with progressive vulvar carcinomas. Brit. J. Cancer, 75, 1217-1218 (1997).
4. DIEZ, M., TORRES, A., MAESTRO, M., ORTEGA, M., GOMEZ, A., POLLAN, M., LOPEZ, J., PICARDO, A., HERNANDO, F. and BALIBREA, J., Prediction of survival and recurrence by serum and cytosolic levels of CEA, CA 125 and SCC antigens in resectable non-small-cell lung cancer. Brit. J. Cancer, 73, 1248-1254 (1996).
5. DI SAIA, P. and CREASMAN, W., Invasive cancer of the vulva. In: P. Di Saia and W. Creasman (eds.), Clinical gynecologic oncology (4th ed.), pp. 238-273, Mosby Year Book, St. Louis (1993).
6. DI SAIA, P., MORROW, C., HAVERBACK, B. and DYCE, B., Carcinoembryonic antigen in cervical and vulvar cancer patients. Serum levels and disease progress. Obstet. Gynecol., 47, 95-99 (1976).
7. DUK, J., GROENIER, K., DE BRUIJN, H., HOLLEMA, H., TEN HOOR, K., VAN DER ZEE, A. and AALDERS, J., Pretreatment serum squamous-cell carcinoma antigen: a newly identified prognostic factor in early-stage cervical carcinoma. J. clin. Oncol., 14, 111-118 (1996).
8. GAARENSTROOM, K., BONFRER, J., KENTER, G., KORSE, C., HART, A., TRIMBOS, J. and HELMERHORST, T., Clinical value of pretreatment serum Cyfra 21-1, tissue polypeptide antigen, and squamous-cell carcinoma antigen levels in patients with cervical cancer. Cancer, 76, 807-813 (1995).
9. GEBAUER, G. and MULLER-RUCHTHOLTZ, W., Tumor marker concentrations in normal and malignant tissues of colorectal cancer patients and their prognostic relevance. Anticancer Res., 17, 2939-2942 (1997).
10. HACKER, N., Vulvar cancer. In: J. Berek and N. Hacker (eds.), Practical gynecological oncology (2nd ed.), Williams and Wilkins, Baltimore (1994).
11. HEFLER, L., OBERMAIR, A., TEMPFER, C., VAN HOUTE, M., MAENNER, G., REINTHALLER, A., LEODOLTER, S. and KAINZ, C., Serum concentrations of squamous-cell carcinoma antigen in vulvar intraepithelial neoplasia and vulvar cancer. Int. J. Cancer 84, 299-303 (1999).
12. HOPKINS, M., REID, G., VETTRANO, I. and MORLEY, G., Squamous-cell carcinoma of the vulva: prognostic factors influencing survival. Gynecol. Oncol., 43, 113-117(1991).
13. KAINZ, C., STEINER, G., GITSCH, G., SLIUTZ, G., MUSTAFA, G. and KOELBL, H., Tissue polypeptide specific antigen (TPS) in der biochemischen Tumordiagnostik. Klin. Lab., 40, 999-1005 (1994).
14. KATO, H. and TORIGUE, T., Radioimmunoassay for tumor antigen of human cervical squamous-cell carcinoma. Cancer, 40, 1621-1628 (1977).
15. LO, S., CHENG, D., NG, T., WONG, L. and NGAN, H., Prognostic significance of tumour markers in endometrial cancer. Tumor Biol., 18, 241-249 (1997).
16. MAULARD-DURDUX, C., TOUBERT, M., HENNEQUIN, C. and HOUSSET, M., Serum tissue polypeptide antigen in bladder cancer as a tumor marker: a prospective study. J. clin. Oncol., 15, 3446-3450 (1997).
17. MELLERICK, D., OSBORN, M. and WEBER, K., On the nature of serological tissue polypeptide antigen (TPA); monoclonal keratin 8, 18, and 19 antibodies react differently with TPA prepared from human cultured carcinoma cells and TPA in human serum. Oncogene, 5, 1007-1017 (1990).
18. MOLL, R., FRANKE, W.W., SCHILLER, D.L., GEIGER, B. and KREPLER, R., The catalog of human cytokeratins: patterns of expression in normal epithelia, tumours and cultured cells. Cell, 31, 11-24 (1982).
19. NAM, J., CHANG, K., CHAMBERS, J., SCHWARTZ, P. and COLE, L., Urinary gonadotropin fragment, a new tumor marker. Use in cervical and vulvar cancer. Gynecol. Oncol., 38, 66-70 (1990).
20. NEMOTO, T., CONSTANTINE, R. and CHU, T., Human tissue polypeptide antigen in breast cancer. J. nat. Cancer. Inst., 63, 1347-1350 (1979).
21. PATSNER, B. and MANN, W., Serum squamous-cell carcinoma antigen levels in patients with invasive squamous vulvar and vaginal cancer: a preliminary report. Gynecol. Oncol., 33, 323-325 (1989).
22. PECTASIDES, D., BAFALOUCOS, D., ANTONIOU, F., ECONOMIDES, N., VARTHALTIS, J., DIMITRIADES, M., KOSMIDIS, P. and ATHANASSIOU, A., TPA, TATI, CEA, AFP, beta-HCG, PSA, SCC, and CA 19-9 for monitoring transitional cell carcinoma of the bladder. Amer. J. clin. Oncol., 19, 271-277 (1996).
23. PETRELLI, N., SHAW, N., BHARGAVA, A., DAUFELDT, J., HERRERA, L., STULC, J., SISCHY, B. and MITTELMANN, A., Squamous-cell carcinoma antigen as a marker for squamous-cell carcinoma of the anal canal. J. clin. Oncol., 6, 782-785 (1988).
24. ROSE, P., BAKER, S., FOURNIER, L., NELSON, B. and HUNTER, R., Serum squamous-cell carcinoma antigen levels in invasive cervical cancer: prediction of response and recurrence. Amer. J. Obstet. Gynecol., 168, 942-946 (1993).
25. ROSE, P., NELSON, B., FOURNIER, L. and HUNTER, R., Serum of squamous-cell carcinoma antigen levels in invasive vulvar cancer. J. surg. Oncol., 50, 183-186 (1992).
26. SUMINAMI, Y., KISHI, F., SEKIGUCHI, K. and KATO, H., Squamous-cell carcinoma antigen is a new member of the serine protease inhibitors. Biochem. biophys. Res. Comm., 181, 51-58 (1991).
27. TEMPFER, C., HEFLER, L., HAEUSLER, G., REINTHALLER, A., KOELBL, H., ZEISLER, H. and KAINZ, C., Tissue polypeptide specific antigen in the follow-up of ovarian and cervical cancer patients. Int. J. Cancer, 79, 241-244 (1998).
28. VAN DER GAAST, A., VAN PUTTEN, W., OOSTEROM, R., COZIJNSEN, M., HOEKSTRA, R. and SPLINTER, T., Prognostic value of serum thymidine kinase, tissue polypeptide and neuron specific enolase in patients with small cell lung cancer. Brit. J. Cancer. 64, 369-372 (1991).
29. VAN DER SIJDE, R., DE BRUIJN, H., KRANS, M., BOUMA, J. and AALDERS, J., Significance of serum SCC antigen as a tumor marker in patients with squamous-cell carcinoma of the vulva. Gynecol. Oncol., 35, 227-232 (1989).
30. YAMAWAKI, T., TAKESHIMA, N., SHIMIZU, Y., TESHIMA, H. and HASUMI, K., Serum levels of squamous-cell carcinoma antigen and carcinoembryonic antigen as tumor markers of vulvar cancer. J. Obstet. Gynaecol. Res., 22, 341-346 (1996).